CRESEMBA 40 mg/mL
isavuconazonium sulfate · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Astellas Pharma US, Inc.
CRESEMBA is a injection, powder, lyophilized, for solution containing isavuconazonium sulfate at 40 mg/mL, taken intravenous. Manufactured by Astellas Pharma US, Inc..
Key Facts
- Brand Name
- CRESEMBA
- Generic Name
- isavuconazonium sulfate
- NDC Code (Product)
0469-0420- Manufacturer
- Astellas Pharma US, Inc.
- Strength
- 40 mg/mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA207501
- Marketing Start
- 03/06/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is CRESEMBA used for?
CRESEMBA contains isavuconazonium sulfate. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is CRESEMBA a controlled substance?
CRESEMBA is not classified as a controlled substance by the DEA.
What is the generic name for CRESEMBA?
The generic name for CRESEMBA is isavuconazonium sulfate. There are no other listed brand versions of isavuconazonium sulfate.
What is the NDC code for CRESEMBA 40 mg/mL?
The NDC (National Drug Code) for CRESEMBA 40 mg/mL is 0469-0420, listed by Astellas Pharma US, Inc..
Other CRESEMBA Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)